These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3839584)

  • 21. Pharmacokinetics of peniobarbital in the cat and comparisons with the rabbit and man.
    Wagner JG; Weidler DJ; Hallmark MR; Black KL; Domino EF
    Res Commun Chem Pathol Pharmacol; 1977 Feb; 16(2):375-84. PubMed ID: 847291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of prednisone and prednisolone at steady state in the rabbit.
    Unadkat JD; Rowland M
    Drug Metab Dispos; 1985; 13(4):503-9. PubMed ID: 2863117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma disposition, metabolism and excretion of the experimental antitumour agent 5,6-dimethylxanthenone-4-acetic acid in the mouse, rat and rabbit.
    Kestell P; Paxton JW; Rewcastle GW; Dunlop I; Baguley BC
    Cancer Chemother Pharmacol; 1999; 43(4):323-30. PubMed ID: 10071984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiotoxicity study of amsacrine in rats.
    Kim SN; Watkins JR; Jayasekara U; Anderson JA; Fitzgerald JE; de la Iglesia FA
    Toxicol Appl Pharmacol; 1985 Mar; 77(3):369-73. PubMed ID: 3838387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and plasma binding of diazepam in man, dog, rabbit, guinea pig and rat.
    Klotz U; Antonin KH; Bieck PR
    J Pharmacol Exp Ther; 1976 Oct; 199(1):67-73. PubMed ID: 789856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Doxorubicin pharmacokinetics in the rabbit.
    Maniez-Devos DM; Baurain R; Trouet A; Lesne M
    J Pharmacol; 1985; 16(2):159-69. PubMed ID: 4058012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CI-921: an analog of amsacrine with experimental activity against solid tumors.
    Grove WR; DeLap LW; Grillo-López AJ
    Invest New Drugs; 1986; 4(2):113-8. PubMed ID: 3755424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of the imidazoacridinone C1311 by high-performance liquid chromatography.
    Calabrese CR; Loadman PM
    J Chromatogr B Biomed Sci Appl; 1997 Mar; 690(1-2):275-81. PubMed ID: 9106053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amsacrine cardiotoxicity: assessment of ventricular function by radionuclide angiography.
    Vorobiof DA; Iturralde M; Falkson G
    Cancer Treat Rep; 1983 Dec; 67(12):1115-7. PubMed ID: 6689141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Biotransformation of 9-(p-methylanilino) acridine in the rabbit].
    He SX; Wang DY; Shi GL; Du XY
    Zhongguo Yao Li Xue Bao; 1983 Mar; 4(1):63-7. PubMed ID: 6223504
    [No Abstract]   [Full Text] [Related]  

  • 31. Interaction of the antitumor drug 4'-(9-acridinylamino)methanesulfon-m-anisidide and related acridines with nucleic acids.
    Wilson WR; Baguley BC; Wakelin LP; Waring MJ
    Mol Pharmacol; 1981 Sep; 20(2):404-14. PubMed ID: 6170872
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of antitumor properties of nitracrine and amsacrine analogs.
    Mazerska Z; Chołody M; Lukowicz J; Wysocka-Skrzela B; Ledóchowski A
    Arzneimittelforschung; 1987 Nov; 37(11):1276-81. PubMed ID: 3326605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gender differences in the metabolism and pharmacokinetics of the experimental anticancer agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA).
    Zhou S; Kestell P; Tingle MD; Paxton JW
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):126-32. PubMed ID: 11862426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thiolytic cleavage and binding of the antitumour agent CI-921 in blood.
    Kestell P; Paxton JW; Robertson IG; Evans PC; Dormer RA; Baguley BC
    Drug Metabol Drug Interact; 1988; 6(3-4):327-36. PubMed ID: 3271644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pharmacokinetics of cyclosporine. II. Blood plasma distribution and binding studies.
    Awni WM; Sawchuk RJ
    Drug Metab Dispos; 1985; 13(2):133-8. PubMed ID: 2859158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacterial and mammalian cell mutagenesis, sister-chromatid exchange, and mouse lung adenoma bioassay with the antineoplastic acridine derivative amsacrine.
    de la Iglesia FA; Fitzgerald JE; McGuire EJ; Kim SN; Heifetz CL; Stoner GD
    J Toxicol Environ Health; 1984; 14(5-6):667-81. PubMed ID: 6394768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmacokinetics of bromotetrandrin (W198) in rats and beagle dogs].
    Xiao SH; Wei GL; Lu R; Liu CX; Wang FP
    Yao Xue Xue Bao; 2004 Apr; 39(4):301-4. PubMed ID: 15303664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and tissue distribution of the imidazoacridinone C1311 in tumour-bearing mice.
    Calabrese CR; Bibby MC; Double JA; Loadman PM
    Cancer Chemother Pharmacol; 1998; 42(5):379-85. PubMed ID: 9771952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential roles for preclinical pharmacology in phase I clinical trials.
    Collins JM; Zaharko DS; Dedrick RL; Chabner BA
    Cancer Treat Rep; 1986 Jan; 70(1):73-80. PubMed ID: 3753662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1.
    Egorin MJ; Zuhowski EG; Rosen DM; Sentz DL; Covey JM; Eiseman JL
    Cancer Chemother Pharmacol; 2001 Apr; 47(4):291-302. PubMed ID: 11345645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.